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Design: An analytic comparative study.
Setting: Radiology Department, Farwania Hospital.
Subjects: Ninety-ﬁve hepatic focal lesions, 61 patients were examined from October 2006 to March
2010. Gold standard was biopsy, radiological and clinical follow up.
Main outcome: The value of CT and MRI in characterizing these lesions was assessed.
Results: The mean sensitivity of MRI was (72.5%) and CT (72.6%) in the detection of overall
hepatic focal lesions. However, the positive predictive value for MRI was 96.1% and for CT was
91.5%. False negative results were the problem of MRI and CT in lesions 62 cm (33.8% and
30.5%, respectively). About lesion characterization, MRI was relatively highly speciﬁc for diagnosis73, Ardia, Kuwait. Tel.: +965
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Conclusion: An analytic comparative study.
 2011 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction and rationale
Advances in imaging techniques, notably computed tomogra-
phy, magnetic resonance imaging and ultrasound have in-
creased our ability to detect and characterize focal liver
lesions, resulting in improvements in diagnostic capability and
improved monitoring of liver focal lesions and metastases (1).
MRI is frequently used as a problem solving technique for
the evaluation of focal hepatic lesions that are deemed indeter-
minate with other imaging modalities particularly in patients
with history of malignancy or with underlying liver diseases
‘‘cirrhosis’’ (2).
MDCT performed statistically better than MRI in lesion
detection (3).
In the preoperative evaluation of HCC, it is important to
diagnose accurately the number and location of HCCs to
choose the most appropriate surgical procedure and improve
therapeutic outcome (4). So, this study was performed to ex-
plore the effectiveness, and hence the clinical utility, of CT
and MR characterization of focal hepatic lesions.2. Patients and methods
The subjects in this study comprised 61 consecutive patients
with 95 hepatic focal lesions. They underwent both MR imag-
ing and 64 MSCT triphasic imaging. The patients included 37nodule (5.5 cm) at segment 4, (B
g nodules.men and 24 women who ranged in age from 19 to 74 years
(mean age, 46.5 years).
Ethical considerations: All the patients had given their in-
formed consent to be included in the study, which was con-
ducted in accordance with the principles of the Declaration
of Helsinki (5).
The 95 focal lesions ranged in size from 4 to 100 mm (mean,
52 mm), 62 were less than or equal to 20 mm in diameter
(range, 4–20 mm; mean, 12 mm), and 33 were greater than
20 mm (range, 21–100 mm; mean, 60.5 mm).
Proof of deﬁnite diagnosis was obtained by biopsy or surgi-
cal resection of 59 lesions in 31 patients. The other lesions,
which were not surgically treated, were conﬁrmed on the basis
of a combination of clinical, laboratory and radiologic criteria,
including a response to treatment (6).
Exclusion criteria: Focal lesions exposed to therapeutic
intervention as surgery, RF ablation, aspiration or chemo-
embolization.
Sample type: Comprehensive sample.
Study design: Analytic, comparative study.3. Methods
CT exams were performed using GE, light speed VCT 64
slices. One hundred and twenty milliliters of a nonionic iodin-
ated contrast agent (Omnipaque 350 mg I/ml, Iohexol, GE,) MRI: (B) non speciﬁc pattern of enhancement, multiple nodules,
Fig. 2 Metastases, gastric cancer, US (A) two hepatic hypoechoic focal lesions. CT showed no focal lesions. MRI, multiple focal lesions
at segment 5, 6, 4b, high on T1 (B and C) low on T2, no suppression on out of phase. After contrast, no enhancement on LAVA asset.
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(4).
MR imaging was performed with a superconducting imager
at 1.5 T (GE Signa HDxt). MR contrast used was OmniscanFig. 3 Metastases, cancer colon, focal lesion at segment 6 with local
surrounding rim of hypodensity on porto-venous phase. MRI, (C) ax
biliary radicals. On T2 central hypo and peripheral hyperintense (targe
peripheral contrast on arterial phase with ﬁlling but no complete ﬁllin(Gadodiamide, 0.5 mmol/ml, GE, Ireland), 0.2 mmol/kg, was
hand-injected IV and followed by a saline ﬂush (2,6).
Ultrasound exams were done used GE LOGIQ 7 & VOLU-
SON 370 GE. The transducer used was (2–5 MHz).pressure. CT: (A) hypodense on arterial phase, (B) isodense with
ial T2 FSE, (D) another lesion is seen at segment 5 with dilated
t sign) and reverse of the same on T1, measuring (23 · 22 mm), (F)
g on the delayed phase.
Fig. 4 Hydatid cyst. Ultrasound (A), a complex (cystic and solid) focal lesion with curvilinear and echogenic dots with posterior
shadowing (calciﬁcations) at segment 8. MRI (B), May 2006 T2 FSE, (C) T1 FatSAt. July 2007. (D) T2 double echo, axial (E) DWI, MRI
28/09/08, noted per-cyst ﬁbrous capsule. Heterogenousity of its internal texture and mild undulation of its outline. No interval changes of
the size.
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Delayed phase enhancement, peripheral washout, ring
enhancement, nodule within a nodule enhancement, true cen-
tral scar, pseudocentral scar, pseudocapsule (7).Fig. 5 FNH, US: iso echoic focal lesion, well deﬁned. CT: hypoattenu
non enhanced area. On venous and delayed phases, the lesion is iso at
T2, central scar low signal on T1 & T2 WI. (B) Dual echo show sign
arterial enhancement with central satellite non enhanced scar. On venou
enhanced central scar.Hypoenhancing benign lesions: Hepatic simple cysts, on CT,
low attenuation (0–10 HU) and do not enhance on contrast
study. Markedly hypointense on T1 WI, markedly hyperin-
tense on T2, no internal enhancement, very thin wall, well de-
ﬁned margins.ating rounded lesion. (A) Arterial phase, enhancement with central
tenuation to the liver. MRI: iso on T1, minimally hyperintense on
al drop out (intracellular fat), not the scar, after contrast, intense
s phase, iso to the liver. On delayed phase, iso to the liver however
Fig. 7 Hemangioma. US: hemangioma segment 6, 7 (A) MRI T2 FSE, (B) axial LAVA multiphase contrast dynamic: peripheral nodular
enhancement in arterial phase, increased enhancement in venous which fading centrally on delayed (C) 5–10 min.
Fig. 6 HCC in cirrhotic liver. US, iso to echogenic focal lesion. CT, (A) hypodense, (B) no arterial signiﬁcant enhancement, (C) but
venous E. and no signiﬁcant washout in delayed phase. MRI: heterogeneous signal lesion, predominantly (E) hypointense on T1, (D)
hyperintense on T2 ‘‘dual echo’’. Post contrast (F), show later arterial and venous phase enhancement without washout on delayed phase.
Rim enhancement seen on delayed phase.
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both T1 & T2 WI with minimal enhancement after contrast
(Fig. 1).
Dysplastic nodules: Generally hypointense or more com-
monly hyperintense on T1 WI, and iso or hypointense on T2WI without prominent arterial phase enhancement (as the
main blood supply is from the portal venous system). Dysplas-
tic nodules are not hyperintense on T2 WI (8).
Malignant hypoenhancing lesions: Hypovascular metastases
(Fig. 2): colon, lung, prostate, gastric and transitional cell car-
Table 1 Pathological diagnosis of focal lesions.
Enhancement Pattern HCC Hemangioma FNH Metastasis Focal fatty inﬁltrations Hydatid cyst Adenoma Total
Homogeneous 13 4 3 4 0 0 0 24
Abnormal internal vessels or variegated 9 1 0 2 0 0 0 12
Peripheral puddles 0 12 0 1 0 0 0 13
Complete ring 7 1 0 9 0 1 1 19
Incomplete ring 0 7 0 1 0 3 0 11
No enhancement 2 0 0 2 2 0 0 6
Total 31 25 3 19 2 4 1 85
Table 2 Detection percentage of different pathological types by CT and MRI.
Diagnosis No of lesions Detection by CT (%) Detection by MRI (%)
Hemangioma 25 80 92
Metastases 19 63.3 84.2
HCC 31 58.6 90.3
Hydatid cyst 4 100 100
Regenerated nodules 5 60 80
Adenoma 1 100 100
FNH 3 100 100
Dysplastic nodules 3 0 66.7
Cholangiocarcinoma 2 50 100
Focal fatty inﬁltrations 2 50 100
Total 95 66.2 91.3
Table 3 The sensitivity and positive predictive values of MRI & CT of the two observers.
Features No of lesions Observer 1 Observer 2
MR (%) CT (%) MR (%) CT (%)
Sensitivity
62 cm 62 42.6 47.4 53.3 49.2
>2 cm 33 97 96.8 96.8 96.9
Total 95 69.8 72.1 75.1 73.1
+ve PV
62 cm 62 96.3 84.4 94.1 90.6
>2 cm 33 100 93.8 93.8 96.9
Total 95 98.2 89.1 94 93.8
106 A. Hassan et al.cinoma, usually show low signals on T1 and iso to hyperin-
tense on T2 with delayed enhancement. Occasionally show
early ring enhancement (Fig. 3).
Focal fat: Displays low signals on CT, shows signal loss on
opposed phase images and no enhancement (9).
Echinococcus infestations: Central necrosis and micro-calci-
ﬁcations are common. CT display heterogeneous hypodense
areas without enhancement. T2 display high signals (Fig. 4)
of peripheral cystic extensions, other lesion are hypointense
on T1 & T2 WI (10).
Benign arterial phase enhancing lesions: Adenoma: hypo-
dense on CT, but may be hyperdense or heterogeneous due
to hemorrhage. Adenomas range from mildly hypo to hyperin-
tense on T1 WI. The high signal due to fat or blood products.
On T2, non speciﬁc heterogeneous slightly hyperintense le-
sions. Immediate enhancement in arterieal phase but rapidly
fades to nearly isointense on delayed phase.Focal nodular hyperplasia (Fig. 5): Appears as hypodense on
CT with central non enhancing scar. On MRI, iso on T1, iso to
hyperintense on T2. Central scar is hyperintense on T2. It dis-
plays arterial enhancement and scar may enhance on delayed
scans (11).
Malignant arterial phase enhancing lesions: HCC, Com-
monly hypodense on CT (Fig. 6). On T1, hypointense,
although high signals lesions or areas of mixed signals may
be seen. High signals within HCC reﬂect fat, copper, protein,
blood. On T2, HCC generally hyperintense, although isoin-
tense lesions may be seen. Most HCC show intense arterial
enhancement. Large HCC may have mosaic pattern (12).
Hypervascular metastases: Islet cell tumors, breast cancer,
melanoma, thyroid cancer, carcinoid. They have high signals
on T2, and arterial enhancement.
Hemangiomas: On CT, it appears as nodular hypodense
homogenous lesions, peripheral, centripetal enhancement in
Table 4 True positive (TP), false positive (FP) and false
negative (FN) values of MRI and CT according to lesion size.
TP FP FN
MRI
62 cm 26.5 3 32.1 (33.8%)
>2 cm 31 1 1
CT
62 cm 30.5 2.5 29 (30.5%)
>2 cm 30.5 1.5 1
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layed phase. On MRI (Fig. 7), it display hypointense lesion on
T1 and hyperintense on T2 and enhanced like CT (13).
4.1. Image analysis
Two blinded observers with at least 5 years experience in inter-
pretation of CT and MRI. Each observer independently re-
corded the presence and segmental location of lesions using
a four-point conﬁdence scale based on previous studies (4):
(1) no focal lesion; (2) probably no focal lesion; (3) probable
focal lesion; (4) deﬁnite focal lesion.
4.2. Statistical analysis
The sensitivity for each observer and technique was calculated,
and the statistical analysis for differences of the sensitivities
was performed with the McNemar test (14). Kappa statistics
were used to assess interobserver agreement in the detection
of focal lesions with each technique (15).
5. Results
After through clinical examination & history taking, the
patient underwent these imaging examinations (Table 1). TheTable 5 Analysis of HCC (31) of the overall 95 focal lesions.
TP TN FP FN Accuracy (%)
HCC (No. 31) MRI 28 56 8 3 88.4
CT 18 55 11 11 76.8
Hemangioma (No. 25)
MRI
23 62 6 4 89.5
CT 20 61 8 6 85.3
Mets (No. 19) MRI 16 65 9 5 85.3
CT 12 63 12 8 78.9
Table 6 Pattern-based classiﬁcation scheme for enhancement at art
Diagnosis Enhancement Pattern
HCC Homogeneous
HCC Abnormal internal vessels or variegated
Hemangioma Peripheral puddles
FNH Homogeneous
Metastasis Complete ring
Metastasis Incomplete ringhepatic focal lesions are categorized according to cystic and so-
lid lesions, size of the lesion (62 cm and >2 cm) (16).
5.1. Lesion detection and characterization
The number of hepatic lesions per sequence on a segment-by-
segment basis. Eight anatomic hepatic segments were deﬁned
on the basis of the numbering system of Couinaud. For CT
density & MRI sequences, it is recorded the segmental location
and the size of each lesion and then assigned as present or ab-
sent (17) (Table 1).
Detection of focal hepatic lesions by CT and MRI for hem-
angioma was 80% in CT and 92% in MRI. In metastases, the
values much less (63.3% and 84.2%, respectively). However,
detection was perfect (100%) in hydatid cyst, FNH and ade-
noma in both CT and MRI (Table 2). In cases of HCC,
MRI could detect 90.3% of cases, whether CT could detect
58.6% only.
The detection sensitivity for tumors of two size categories
(<2 cm or P2 cm) and the positive predictive values for each
of the two observers are shown in Table 4. Using MR imaging
alone, observers 1, 2 detected 42.6% and 53.3% of focal le-
sions less than or equal to 2 cm and detect 97%, 96.8% of focal
lesions more than 2 cm, respectively. Using MDCT, they de-
tect 47.4% and 49.2% of lesions less than or equal to 2 cm,
and 84.4%, 90.6% of lesions more than 2 cm (see Table 3).
The problem as shown in Table 4 is noted in the elevated
false negative values of CT and MRI in lesions less than 2 cm.
Thirty-one focal lesions were ﬁnally diagnosed as HCC.
Speciﬁcity and sensitivity of CT were 83.3% & 62%, whereas,
MRI speciﬁcity and sensitivity were 87.5% & 83.3%. In
hemangiomas, 25 lesions were detected and characterized.
Speciﬁcity and sensitivity of CT were 88.4% & 76.9%,
whereas, MRI speciﬁcity and sensitivity were 91.2% &
85.2%. In metastases, 19 focal lesions were examined. The
speciﬁcity and sensitivity of CT & MRI were 84%, 60%,
87.8% & 76.2%, respectively (Table 5).Sensitivity (%) Speciﬁcity (%) +ve PV (%) ve PV (%)
90.3 87.5 77.8 94.9
62 83.3 62.1 82.1
85.2 91.2 79.3 93.9
76.9 88.4 71.4 91
76.2 87.8 64 92.9
60 84 50 88.7
erial phase.
Sensitivity (%) Speciﬁcity (%) PPV (%)
41.9 86.7 54.2
29 96 75
48 98.4 92.3
100 79.6 12.5
47.4 86.8 47.4
5.3 86.8 9.1
108 A. Hassan et al.Enhancement pattern in arterial phase was analyzed (Table
6). In HCC, the most speciﬁc pattern was abnormal internal
vessels (96%). In cases of hemangiomas, peripheral puddles
were highly speciﬁc (98.4%). In metastases, enhancement pat-
tern was not highly speciﬁc in both complete and incomplete
ring (86.8%, for each).
The kappa values for the three observers, calculated on the
basis of each observer’s conﬁdence level for the alternative
free-response ROC analysis, were 0.77 for MR imaging and
0.79 for CT and showed substantial agreement with regard
to the presence of lesions.
In all the patients, MDCT provided the optimum arterial
and venous images without any signiﬁcant motion or
artifacts.
A total of 31 HCC were ascertained pathologically. In CT,
the typical signs of HCC were hyperattenuation in the hepatic
arterial phase and hypoattenuation in the portal venous phase
and delayed phase. MSCT had a sensitivity of 62% and its
false-positive rate was 35.5% (11/31).
Carcinoma thrombosis was detected in the left branch of
the portal vein in one patient and in the right branch in two
patients. The transverse diameter of the involved portal vein
ranged from 12 cm to 25 mm. three patients were accompanied
with some degree of cavernous transformation of the portal
vein.
In two patients MRI & MSCT images revealed tumor
involvement of the biliary duct, which was dilated. In two
patients, peritoneal implants were conﬁrmed surgically, but
were not demonstrated by MRI & MSCT before
operation.6. Discussion
In a meta-analysis of hepatic metastases from cancers of
the gastrointestinal tract, Kinkel et al. (18), reported a
mean sensitivity of 72% for CT, based on 25 publications
that included 1747 patients. In another study with surgi-
cally proven liver lesions, a sensitivity of 69–71% and a
speciﬁcity of 86–91% was shown using dual-phase helical
CT (15).
In a study of Khalid et al. (2), 55% diagnosis of meta-
static focal hepatic lesions by MRI as compared with 17%
for CT. In our study, the sensitivity and speciﬁcity of CT
were 60%, 84% and for MRI were 76.2%, 87.8% in metas-
tases. The numbers is different along these studies because
of undetermined lesion size mentioned in the other studies;
however, there is a difference in resolution of using MSCT
in this study.
More recent comparisons of noninvasive imaging modali-
ties, primarily MDCT and MRI, have shown equally accurate
if not better lesion detection of MDCT.
Advancements in both MRI hardware and image acquisi-
tion techniques have had a major impact in abdominal imag-
ing, particularly hepatic imaging (19,20). however, in our
study, in hemangiomas, the sensitivity and speciﬁcity of CT
were 76.9%, 88.4% and for MRI were 85.2%, 91.2%, whereas,
in HCC, the sensitivity and speciﬁcity of CT were 62%, 83.3%
and for MRI were 90.3%, 87.5% in metastases, sensitivity and
speciﬁcity of CT were 60%, 84% and for MRI were 76.2%,
87.8%. These results are somewhat like in previous studies,
as mentioned (4,21).In study using 64 MDCT and MRI (4), about detection
sensitivity of MRI and MSCT, the differences between the
two techniques were insigniﬁcant. Also, the numbers of false-
positive MRI ﬁndings were the same as or relatively low com-
pared with those for MSCT. Eighty percent of the false-posi-
tive MRI results and 67% of the false-positive CT results
were primarily attributed to arterioportal shunt. In our study,
MRI was almost the same as CT to detect focal hepatic lesions,
whether small, lesions 62, sensitivity of MRI was 48% and CT
was 48.3%, and also in lesions >2 cm, sensitivity of MRI was
96.9% and CT was 96.9%, however, the speciﬁcity of MRI is
signiﬁcantly higher than CT. Also, Cirrhosis-related benign
nodules may exhibit predominant hypoattenuation on con-
trast-enhanced portal or delayed phase CT images (22) and
might not be differentiated from hypovascular HCC. In the
same study of Seong et al. 33% of false-positive ﬁndings on
MDCT were attributed to prominent cirrhosis-related nodules,
in our study, 11 cases of false positive HCC lesions, ﬁve of
them related to cirrhosis-related nodules (45.5%). In that
study, the numbers of false-negative MRI ﬁndings were rela-
tively low compared with the false-negative MDCT ﬁndings.
In our study, 11 lesions of false negative in CT whereas, only
three lesions in MRI.
A study by Matilde et al. (23), 92% of the 100 lesions dem-
onstrated arterial enhancement. Patterns associated with posi-
tive predictive values of 82% or greater and speciﬁcity of 80%
or greater included abnormal internal vessels or variegated
(hepatocellular carcinoma), peripheral puddles (hemangioma)
(Fig. 2), and complete ring (metastasis). In our study, arterial
enhancement is seen in 100% of HCC, hemangioma and
metastases. Our study is matched with this study, as abnormal
internal vessels was speciﬁc for HCC (96%), peripheral pud-
dles (hemangioma, 98.4% speciﬁc), complete and incomplete
ring (metastasis, 86.8%).
The abnormal internal vessels or variegated pattern indi-
cated HCC with a PPV of 75% and a speciﬁcity of 96%. It dis-
plays either abnormal internal vessels or randomly distributed
components of both hyperattenuation and hypoattenuation.
The deﬁnition for abnormal internal vessels required vessels
to be irregular in contour or to branch erratically, ﬁndings that
reﬂected neovascularity associated with malignancy in angio-
graphic studies.
The peripheral puddles pattern was associated with heman-
giomas, the PPV and speciﬁcity of this pattern for hemangi-
oma were 92.3% and 98.4%, respectively. The appearance of
discrete well-deﬁned peripheral globules isoattenuating with
vascular structures has been well established as characteristic
of hemangiomas (24).
Lesions with circumferential ring enhancement usually
malignant. When all lesions exhibiting this enhancement pat-
tern were considered, malignancy was predicted, as speciﬁcity
for metastases was 86.8%.
An important observation is that overlap can occur be-
tween the appearances of benign and malignant lesions. For
example, as found in this study and others (23), the homoge-
neous pattern can be exhibited by lesions such as HCC,
hemangiomas, and FNH. Additionally, we found overlap be-
tween the peripheral puddles pattern typical of hemangiomas
and the enhancement exhibited by metastasis. Correlation with
portal venous phase images may help differentiate lesions that
exhibit similar arterial phase enhancement patterns. Few
hemangiomas and hypervascular metastases were included in
Sixty-four multi-slice computed tomography and magnetic resonance imaging in evaluation of hepatic focal lesions 109our study, and further work will be necessary to more fully
examine their enhancement patterns.
In the study, seven cases of HCC (22.6%), had ring and
peripheral enhancement. The appearance of HCC depends
largely on tumor size and histologic grade. Small HCC have
a proportionately greater arterial hepatic blood supply and
as a result they may be visible on arterial phase with wash-
out on portal phase. In larger lesions, the portal vein may
also contribute signiﬁcantly to the blood supply of HCC en-
abling its visualization on porto-venous phase as well, how-
ever, because large tumor may contain areas of hemorrhage
or necrosis, they may be seen as either hyper or hypodense
during arterial phase. Irregular mosaic or peripheral
enhancement is usually seen in larger HCC depending on
the internal architecture (25). In moderately differentiated
HCC, peak of enhancement is seen on arterial phase with
rapid washout in portal and delayed phases, however, grad-
ual increasing enhancement overtime is found in poorly dif-
ferentiated scirrhous HCC, also HCC pseudo capsule
congaing abundant granulation tissue usually enhanced on
venous and delayed phases (26).
FNH, in as many as 20% of patients, a scar may not be vis-
ible (27), but in our study, all cases presented with scar. One
case of FNH displays drop out signal on out of phase (fatty
contents), except the central scar, the authors considered it
as an exaggerated expression of this patient’s native hepatic
disease characterized by fatty liver (28,29).
Cases of false negative equal to 2 cm or smaller in diameter
were not detected with MDCT or MRI by any observer, exhib-
ited poor conspicuity and subtle hypervascularity on arterial
phase images; in two of the lesions no washout pattern was
seen on delayed CT scans. The observers considered these
HCCs arterioportal shunts and misidentiﬁed them at CT image
interpretation.
7. Conclusion
MSCT continues to be limited in the detection of small lesions
which usually have a greater chance of exhibiting poor conspi-
cuity and no washout pattern, for lesions that mimic arterio-
portal shunts, MRI has advantages over MDCT.
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